openPR Logo
Press release

Rising Skin Cancer Cases Drive Growth In Isotretinoin Drugs Market: Transformative Forces Shaping the Isotretinoin Drugs Market Landscape in 2025

09-15-2025 10:08 AM CET | Health & Medicine

Press release from: The Business Research Company

Isotretinoin Drugs

Isotretinoin Drugs

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Isotretinoin Drugs Industry Market Size Be by 2025?
The market for isotretinoin drugs has seen a consistent uptick in recent years. The size of this market is anticipated to rise from $1.29 billion in 2024 to reach a value of $1.35 billion in 2025, boasting an impressive compound annual growth rate (CAGR) of 4.7%. Factors like the widespread occurrence of severe acne, efficacy of isotretinoin, promotional and consciousness drives, regulatory consent, and a surge in dermatology appointments have fueled growth in the past years.

What's the Long-Term Growth Forecast for the Isotretinoin Drugs Market Size Through 2029?
The market size for isotretinoin drugs is predicted to experience consistent expansion in the coming years, with projections estimating it to attain a value of "$1.63 billion" by 2029, expanding at a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth over the forecast period include heightened awareness and trend towards skincare, growth in nascent markets, rising cases of acne, an aging demographic, as well as an increasing emphasis on mental health and well-being. Key trends to look out for in this forecast period encompass research and development, advancements in technology, innovations in generic drugs, enhanced formulations, and progression in the field of dermatology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/isotretinoin-drugs-global-market-report

What Are the Key Growth Drivers Fueling the Isotretinoin Drugs Market Expansion?
The isotretinoin drugs market is projected to expand due to an increase in skin cancer cases. Skin cancer arises from the unrestrained multiplication of abnormal skin cells, often due to extended exposure to ultraviolet (UV) radiation from the sun or tanning beds. Higher instances of skin cancer are largely from increased UV radiation exposure, along with contributing factors such as the depletion of the ozone layer and changes in lifestyle that result in more outdoor time without sufficient sun protection. Isotretinoin drugs, which have the capability to curb the growth of abnormal skin cells, are utilized in the prevention and treatment of specific types of skin cancer. For example, the American Cancer Society, a US-based non-profit committed to eradicating cancer, has predicted 108,270 skin cancer cases in January 2024, a 3.2% increase from the previous year's 104,930 cases. Hence, the upward trend in skin cancer cases will drive the expansion of the isotretinoin drugs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16095&type=smp

What Long-Term Trends Will Define the Future of the Isotretinoin Drugs Market?
Leading firms in the isotretinoin drugs industry are concentrating on improving formulations like isotretinoin capsules to increase treatment choices and patient accessibility. These capsules are used for complex acne instances like nodular or cystic acne, and necessitate strict adherence to usage instructions due to their severe side effects, notably a heightened risk of birth defects. In July 2023, for example, the US pharmaceutical company Upsher-Smith Laboratories, LLC released the first-ever Isotretinoin Capsules USP in dosages of 10 mg, 20 mg, 30 mg, and 40 mg. These capsules, therapeutically equivalent to the Accutane brand (TE code AB1), offer a verified remedy for extreme acne cases.

How Is the Isotretinoin Drugs Market Segmented?
The isotretinoin drugs market covered in this report is segmented -

1) By Form: Capsules, Injection
2) By Indication Type: Severe Acne, Neuroblastoma, Cutaneous T-Cell Lymphoma, Harlequin Ichthyosis, Xeroderma Pigmentosum, Fibrodysplasia Ossificans Progressiva, Squamous Cell Skin Cancers, Other Indication Types
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Capsules: Soft Gel Capsules, Hard Gel Capsules, Liquid-Filled Capsules
2) By Injection: Intravenous Injection, Intramuscular Injection

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16095&type=smp

Which Companies Are Leading the Charge in Isotretinoin Drugs Market Innovation?
Major companies operating in the isotretinoin drugs market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Hetero Drugs Ltd., Sun Pharmaceuticals Industries Limited, Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Cipla Limited, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc, Zydus Lifesciences Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd, Almirall LLC, Alembic Pharmaceuticals Ltd, Ajanta Pharma Ltd, Strides Pharma Science Limited, Wockhardt Ltd., Douglas Pharmaceuticals Limited, Chongqing Huapont Pharm Co. Ltd., Cipher Pharmaceuticals Inc., Vidhyasha Pharmaceuticals

Which Regions Are Leading the Global Isotretinoin Drugs Market in Revenue?
North America was the largest region in the isotretinoin drugs market in 2024. The regions covered in the isotretinoin drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16095

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Skin Cancer Cases Drive Growth In Isotretinoin Drugs Market: Transformative Forces Shaping the Isotretinoin Drugs Market Landscape in 2025 here

News-ID: 4182476 • Views:

More Releases from The Business Research Company

Mucolipidosis II Market Expansion Continues, with Forecast Valuation of $15.7 Billion by 2029
Mucolipidosis II Market Expansion Continues, with Forecast Valuation of $15.7 Bi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Mucolipidosis II Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for mucolipidosis II has been consistently increasing over the past few years. Expected to rise from a value of $13.13 billion in 2024 to $13.59 billion in 2025, the market is set
In-Vitro Lung Model Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
In-Vitro Lung Model Market Landscape to 2034: Key Forces Shaping the Next Decade …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the In-Vitro Lung Model Market Size By 2025? Recently, the size of the in-vitro lung model market has seen rapid expansion. Its forecasted growth predicts an increase from $0.44 billion in 2024, to $0.54 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 21.0%.
Top Market Shifts Transforming the Melatonin Supplements Market Landscape: Key Insights
Top Market Shifts Transforming the Melatonin Supplements Market Landscape: Key I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Melatonin Supplements Market Through 2025? The market for melatonin supplements has experienced exponential growth in recent years, with its value expected to grow from $2.37 billion in 2024 to $2.7 billion in 2025, representing a compound annual growth rate (CAGR) of 14.0%.
Guillain-Barre Syndrome Drugs Market Expected to Achieve 7% CAGR by 2029: Growth Forecast Insights
Guillain-Barre Syndrome Drugs Market Expected to Achieve 7% CAGR by 2029: Growth …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Guillain-Barre Syndrome Drugs Market Size By 2025? The market size for drugs treating Guillain-Barre syndrome has seen substantial growth in recent years. The industry's value is projected to increase from $1.17 billion in 2024 to $1.25 billion in 2025, resulting in a compound annual growth

All 5 Releases


More Releases for Pharm

Fenbendazole Market Size, Share and Forecast By Key Players-Jin Dun Pharm, Shand …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Fenbendazole market is anticipated to grow at a compound annual growth rate (CAGR) of 16.05% between 2024 and 2031. The market is expected to grow to USD 68 Billion by 2024. The valuation is expected to reach USD 192.77 Billion by 2031. The fenbendazole market is experiencing notable growth due to increasing awareness of parasitic infections in both
Revolutionizing Revenue: Dexlansoprazole Sustained Release Capsule Market Trends …
Worldwide Market Reports announces the publication of its most recently generated research report titled, "Dexlansoprazole Sustained Release Capsule Market - Forecast to 2030", which offers a holistic view of the Dexlansoprazole Sustained Release Capsule market through systematic segmentation that covers every aspect of the target market. Dexlansoprazole Sustained Release Capsule with 100+ market data Tables, Pie Chat, Graphs, and Figures spread through Pages and easy-to-understand detailed analysis. The information is
Paromomycin Sulfate Market 2030 by Top 10+ Players Pfizer,, Changrui Pharm,, ERF …
Paromomycin Sulfate is an antibiotic used to treat infections caused by certain parasites. It is commonly used to treat visceral leishmaniasis, a serious parasitic disease that affects the internal organs. The market for Paromomycin Sulfate is relatively small compared to other antibiotics, as it is primarily used to treat a specific type of parasitic infection. However, the market for Paromomycin Sulfate is expected to grow as the incidence of visceral
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the